Back

Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia

16 April 2023 (09:40 - 10:40)
Organised by:
Congress Presentation Part of: Ventricular Arrhythmias and SCD - Round 1 - SCD Drug Treatment of Ventricular Arrhythmias EHRA Premium Access EHRA 2023

About the speaker

Photo
Mr Auke Bergeman

Academic Medical Centre, Amsterdam (Netherlands (The))

9 More presentations in this session

Presentation thumbnail
Whole genome sequencing in the 100,000 Genomes project identifies a RYR2 variant associating with dilated cardiomyopathy and sudden unexpected death in the young
Doctor Y. Ben-Haim (London, GB)
Abstract Slides
Presentation thumbnail
Genetic testing in children with Brugada syndrome: results from a large prospective registry
Doctor L. Pannone (Brussels, BE)
Abstract Slides
Presentation thumbnail
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort
Doctor A. Seganti (Milan, IT)
Abstract Slides
Presentation thumbnail
Resting heart rate does not refine risk stratification of sudden cardiac death in the general population
Mr P. Warming (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Familial predisposition to cardiovascular disease and death in patients with an out-of-hospital cardiac arrest
Mr M. Gylling (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Ventricular Arrhythmias and SCD - Round 1 - SCD

The Event

Event poster

EHRA 2023

16 April 2023 09:40 CET
You may be interested in
thumbnail
Congress Session
Ventricular storm (2)
thumbnail
Congress Session
The storm will pass…
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources